Creon

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1987-2014
012319872014

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
BACKGROUND Pancreatic enzyme replacement therapy is the foundation of nutritional management for exocrine pancreatic… (More)
Is this relevant?
2014
2014
BACKGROUND Alkalinized Viokase pancreatic enzyme tablets restored patency to 71.9% of occluded Dobhoff tubes in a prospective… (More)
  • table 1
  • table 2
Is this relevant?
2010
2010
Exocrine pancreatic insufficiency (EPI) is a deficiency of digestive enzymes caused by diseases such as cystic fibrosis (CF… (More)
  • figure 1
  • table I
  • table II
  • table III
  • figure 2
Is this relevant?
2009
2009
The aim of the study was to evaluate efficiency of creon substitution therapy of severe primary pancreatic insufficiency in the… (More)
Is this relevant?
2009
2009
BACKGROUND Pancreatic enzyme replacement therapy is critical for adequate nutrition in cystic fibrosis (CF) patients with… (More)
Is this relevant?
2009
2009
OBJECTIVES To evaluate the efficacy and safety of a pancreatic enzyme preparation specifically developed for infants and small… (More)
Is this relevant?
2006
2006
OBJECTIVES Creon 10 Minimicrospheres is an enteric-coated, delayed-release pancrelipase preparation designed to deliver active… (More)
Is this relevant?
2004
2004
After oral intake, small amounts of intact protein may be absorbed into the blood circulation. The current study investigated… (More)
Is this relevant?
2002
2002
Creon 10,000 Minimicrospherestrade mark (Creon) 10,000 MMS) is a pancreatic enzyme formulation that contains smaller spheres of… (More)
Is this relevant?
1987
1987
Four different pancreatin products, Pancrease, Creon, Pancrex V Forte, and Pancreatin Merck, were compared in a random crossover… (More)
Is this relevant?